Skip to Content

BICO Group AB Class B BICO

Morningstar Rating
SEK 43.92 −0.42 (0.95%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

BICO is trading at a 91% premium.
Price
SEK 44.33
Fair Value
SEK 67.37
Uncertainty
Extreme
1-Star Price
SEK 773.50
5-Star Price
SEK 68.50
Economic Moat
Wgj
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if BICO is a good fit for your portfolio.

Trading Information

Previous Close Price
SEK 44.34
Day Range
SEK 43.5045.50
52-Week Range
SEK 23.3872.30
Bid/Ask
SEK 43.74 / SEK 43.96
Market Cap
SEK 3.10 Bil
Volume/Avg
105,059 / 341,294

Key Statistics

Price/Earnings (Normalized)
Price/Sales
1.43
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

BICO Group AB is a bio-convergence company. It is divided into three business areas: Bioprinting (CELLINK, MatTek, Visikol, and Nanoscribe), Biosciences (CYTENA, CYTENA Bioprocess Solutions, Dispendix, and Discover Echo), and Bioautomation (SCIENION, CELLENION, and Ginolis).
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Small Value
Total Number of Employees
837

Comparables

Valuation

Metric
BICO
MCAP
PLEJD
Price/Earnings (Normalized)
38.8052.22
Price/Book Value
1.036.706.19
Price/Sales
1.434.415.20
Price/Cash Flow
23.6228.78
Price/Earnings
BICO
MCAP
PLEJD

Financial Strength

Metric
BICO
MCAP
PLEJD
Quick Ratio
1.741.351.11
Current Ratio
2.522.232.28
Interest Coverage
−20.0214.8027.22
Quick Ratio
BICO
MCAP
PLEJD

Profitability

Metric
BICO
MCAP
PLEJD
Return on Assets (Normalized)
−4.62%10.75%9.16%
Return on Equity (Normalized)
−7.26%17.72%13.01%
Return on Invested Capital (Normalized)
−6.72%13.91%13.07%
Return on Assets
BICO
MCAP
PLEJD
See how this stock stacks up to its competitors with Morningstar Investor

Medical Devices Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ABT
Abbott LaboratoriesYlpfnhhgWlncnd$182.4 Bil
SYK
Stryker CorpNpgxxqhzSkyz$127.2 Bil
MDT
Medtronic PLCQkrrvjbbdNvdhw$113.7 Bil
BSX
Boston Scientific CorpYzzpjxfjkTwjqwqr$109.6 Bil
EW
Edwards Lifesciences CorpNffzhkmjcBctptr$54.3 Bil
DXCM
DexCom IncNkwrgfwxKvzb$52.2 Bil
PHG
Koninklijke Philips NV ADRMhdnqzjMfqrpyd$25.9 Bil
ZBH
Zimmer Biomet Holdings IncMssmlztnPtkkv$24.9 Bil
ALGN
Align Technology IncMvxkrydqZmlwxlt$20.6 Bil
SNN
Smith & Nephew PLC ADRPnhnmynysRtmgcv$11.4 Bil

Sponsor Center